Paxlovid, Pfizer’s COVID-19 antiviral pill, has been shown to prevent severe COVID-19 and death. An online post alleging the drug is a “fraud” and “should be taken off the market” neglects to mention this important information, and falsely says ivermectin is superior.
Clinical Trials Find No Increase in Mortality Among COVID-19 Patients Treated with Remdesivir, Contrary to Viral Claim
Remdesivir is the only antiviral medication approved by the Food and Drug Administration to treat COVID-19. But a retired chiropractor misleadingly claims on a viral clip on social media that the drug is “killing people.” Studies have shown that remdesivir can lead to faster recovery times for hospitalized patients.
The National Institutes of Health has not recommended and the Food and Drug Administration has not approved ivermectin as a COVID-19 treatment. But a Facebook post misleadingly implies that an article published on the NIH website is an endorsement of the drug to treat COVID-19. The NIH and FDA have said more clinical studies are needed.
A Japanese company found that the antiparasitic drug ivermectin showed an “antiviral effect” against the omicron variant in a lab setting. Reuters has corrected a story in which it “misstated” that the drug was effective in a phase 3 clinical trial with human subjects. Some social media users have repeated Reuters’ reporting error but have not repeated the correction.
In a Dec. 8 town hall meeting, Sen. Ron Johnson may have left a misleading impression in saying “standard gargle, mouthwash, has been proven to kill the coronavirus.” In the laboratory, some mouthwashes have been shown to block infectivity or suppress SARS-CoV-2, but studies involving people using mouthwash are not conclusive. Researchers are continuing to study the matter.
More than 70% of Japan’s population has received the COVID-19 vaccines, and the government is moving ahead with a booster shot in December. But a conservative radio host in the U.S. falsely claimed, “Japan drops vax rollout, goes to Ivermectin.” Japan hasn’t stopped its vaccine program and hasn’t approved ivermectin as a COVID-19 treatment.
Merck and Pfizer are each developing a new oral antiviral drug that might prevent or treat COVID-19. The pills are very different from the antiparasitic medication ivermectin, contrary to claims online that they are “suspiciously similar” or that the companies are “repackaging” ivermectin in a ploy to increase profits.